XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   13,986,000        
Beginning balance at Dec. 31, 2022 $ 2,596 $ 1 $ (34,251) $ 388,184 $ 181 $ (351,519)
Beginning balance (in shares) at Dec. 31, 2022     1,021,000      
Increase (Decrease) in Equity            
Net income (loss) 21,322         21,322
Foreign currency translation adjustment (34)       (34)  
Stock issued under employee stock purchase plan (in shares)     (8,000)      
Stock issued under employee stock purchase plan 33     33    
Restricted stock granted (in shares)   2,000        
Restricted stock forfeited (in shares)   (7,000) 64,000      
Restricted stock units vested (in shares)   82,000        
Forfeited stock options purchased (617)     (617)    
Stock compensation expense (836)     (836)    
Shares withheld to cover taxes (in shares)     36,000      
Shares withheld to cover taxes (229)   $ (229)      
Issuance of stock warrants, net of transaction fee 15,092     15,092    
Equity contribution 11,040     11,040    
Conversion of convertible notes payable to Common Stock (in shares)   1,723,000        
Conversion of convertible notes payable to Common Stock 8,997 $ 1   8,996    
Conversion of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable to Common Stock (in shares)   10,583,000        
Conversion of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable to Common Stock 40,638 $ 1   40,637    
Ending balance (in shares) at Jun. 30, 2023   26,369,000        
Ending balance at Jun. 30, 2023 98,002 $ 3 $ (34,480) 462,529 147 (330,197)
Ending balance (in shares) at Jun. 30, 2023     1,113,000      
Beginning balance (in shares) at Mar. 31, 2023   15,768,000        
Beginning balance at Mar. 31, 2023 57,138 $ 2 $ (34,451) 421,603 160 (330,176)
Beginning balance (in shares) at Mar. 31, 2023     1,074,000      
Increase (Decrease) in Equity            
Net income (loss) (21)         (21)
Foreign currency translation adjustment (13)       (13)  
Stock issued under employee stock purchase plan (in shares)     (4,000)      
Stock issued under employee stock purchase plan 13     13    
Restricted stock forfeited (in shares)     36,000      
Restricted stock units vested (in shares)   18,000        
Stock compensation expense 276     276    
Shares withheld to cover taxes (in shares)     7,000      
Shares withheld to cover taxes (29)   $ (29)      
Conversion of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable to Common Stock (in shares)   10,583,000        
Conversion of Amended ProFrac Agreement Contract Consideration Convertible Notes Payable to Common Stock 40,638 $ 1   40,637    
Ending balance (in shares) at Jun. 30, 2023   26,369,000        
Ending balance at Jun. 30, 2023 $ 98,002 $ 3 $ (34,480) 462,529 147 (330,197)
Ending balance (in shares) at Jun. 30, 2023     1,113,000      
Beginning balance (in shares) at Dec. 31, 2023 30,772,837 30,773,000        
Beginning balance at Dec. 31, 2023 $ 101,960 $ 3 $ (34,504) 463,140 127 (326,806)
Beginning balance (in shares) at Dec. 31, 2023 1,108,707   1,109,000      
Increase (Decrease) in Equity            
Net income (loss) $ 3,536         3,536
Foreign currency translation adjustment 58       58  
Stock issued under employee stock purchase plan (in shares)     (19,000)      
Stock issued under employee stock purchase plan 62     62    
Restricted stock granted (in shares)   94,000        
Restricted stock forfeited (in shares)     11,000      
Stock compensation expense 642     642    
Shares withheld to cover taxes (in shares)     6,000      
Shares withheld to cover taxes $ (24)   $ (24)      
Ending balance (in shares) at Jun. 30, 2024 30,866,597 30,867,000        
Ending balance at Jun. 30, 2024 $ 106,234 $ 3 $ (34,528) 463,844 185 (323,270)
Ending balance (in shares) at Jun. 30, 2024 1,107,442   1,107,000      
Beginning balance (in shares) at Mar. 31, 2024   30,773,000        
Beginning balance at Mar. 31, 2024 $ 103,898 $ 3 $ (34,514) 463,484 169 (325,244)
Beginning balance (in shares) at Mar. 31, 2024     1,112,000      
Increase (Decrease) in Equity            
Net income (loss) 1,974         1,974
Foreign currency translation adjustment 16       16  
Stock issued under employee stock purchase plan (in shares)     (9,000)      
Stock issued under employee stock purchase plan 28     28    
Restricted stock granted (in shares)   94,000        
Stock compensation expense 332     332    
Shares withheld to cover taxes (in shares)     4,000      
Shares withheld to cover taxes $ (14)   $ (14)      
Ending balance (in shares) at Jun. 30, 2024 30,866,597 30,867,000        
Ending balance at Jun. 30, 2024 $ 106,234 $ 3 $ (34,528) $ 463,844 $ 185 $ (323,270)
Ending balance (in shares) at Jun. 30, 2024 1,107,442   1,107,000